Isec Healthcare Ltd · SGX:40T
Isec Healthcare — Shareholder Meeting (April 2025)
25 slides from Isec Healthcare's shareholder meeting presentation, Apr 21, 2025
Slide 1: ISEC Healthcare Ltd. 11th Annual General Meeting
VISION-FOCUSED FUTURE READY ISEC Healthcare Ltd. (“ISEC Healthcare” or the “Company”) 11th Annual General Meeting 21st April 2025 Page 0
Slide 2: Sponsor statement
This presentation has been prepared by the Company and its contents have been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”) in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the “SGX-ST”) Listing Manual
Slide 3: Disclaimer
Disclaimer This presentation is being furnished to you solely for your information and may not be reproduced or redistributed to any other person or published, in whole or in part, for any purpose. No representation or warranty, express or implied, of any nature is given as to, and no reliance shoul
Slide 4: Table of Content
Table of Content Business Overview Financial Highlights Corporate Developments Outlook Page 3
Slide 5: Business Overview
Business Overview Page 4
Slide 6: Introduction – Our Presence
Introduction Our Presence Malaysia Singapore Melaka Johor Kuala Lumpur Penang Myanmar Ipoh Kampar Teluk Intan Manjung Sibu Taiping Klang Kuching Page 5
Slide 7: Business Overview – Our Presence
Business Overview Our Presence Penang Number of Eye Care Centres (as at 21st April 2025): Ipoh, Kampar, Manjung, Telok Intan, Taiping Malaysia – 12 Singapore – 1 (N1) Kuala Lumpur Myanmar – 1 Klang N1 – Asia Pacific Eye Centre in Gleneagles Hospital. Kuching Sibu Melaka Johor Page 6
Slide 8: Our Competitive Strengths
Business Overview Our Competitive Strengths 1 Highly qualified and experienced specialist doctors 6 Business model aligns the 2 interests of our High quality and specialist doctors with comprehensive range of our Group and eye care services Shareholders 5 Ability to replicate our 3 Well positioned t
Slide 9: Financial Highlights
Financial Highlights Page 8
Slide 10: Key Financial Highlights
Key Financial Highlights Financial Year Ended 31 December 2024 Revenue Gross Profit Margin S$74.2 Million 44.0% 6% YoY Profit After Tax Net Profit Margin S$12.9 Million -2% YoY 17.4% (Excluding Goodwill Impairment: (Excluding Goodwill Impairment: S$14.4 Million) 10% YoY 19.4%) Page 9
Slide 11: Revenue – 5 Years (2020 – 2024)
Financial Highlights Revenue – 5 Years (2020 – 2024) S$’Million S$4.2 mil (6%) S$7.0 mil (11%) S$22.5 mil (56%) S$4.2 mil (11%) The Group’s revenue increased by 6%, from S$70.0 million in FY2023 to S$74.2 million in FY2024. Generally, the Group showed an upward trend on revenue growth between FY2020
Slide 12: Revenue Breakdown – By Business Segment
Financial Highlights Revenue Breakdown – By Business Segment Revenue (S$’Million) and Contribution Percentage by Business Segment S$’Million 6% Specialised Health Services: Revenue increased by S$4.6 million, or 7%, compared to that in FY2023 following the increase in specialised health business act
Slide 13: Revenue Breakdown – By Geographical Segment
Financial Highlights Revenue Breakdown – By Geographical Segment Revenue (S$’Million) and Contribution Percentage by Geographical Segment S$’Million 6% Malaysia: Revenue increased by S$3.6 million, or 6% compared to that in FY2023. The business activities have increased in FY2024 and the number of s
Slide 14: Profit attributable to owners of Company – 5 Years
Financial Highlights Profit attributable to owners of Company – 5 Years (2020 – 2024) -S$0.2 mil (-2%) S$’Million In FY2024, profits decreased marginally by S$0.2 million, or 2%, from S$13.0 million in FY2023 to S$12.8 million in FY2024. The Group recognised one-off impairment loss for goodwill aris
Slide 15: Earnings Per Share – 5 Years (2020 – 2024)
Financial Highlights Earnings Per Share – 5 Years (2020 – 2024) Singapore Cents -0.03 cents (-1%) Earnings per share decreased from 2.26 Singapore cents in FY2023 to 2.23 Singapore cents in FY2024. Should the impairment loss for goodwill be excluded, earnings per share would have been 2.49 Singapore
Slide 16: Net Asset Value attributable to owners – 5 Years
Financial Highlights Net Asset Value attributable to owners of Company – 5 Years (2020 – 2024) Net Asset Value attributable to owners of Company Net Asset Value Per Share (S$) (S$’Million) S$’Million S$9.4 mil (12%) S$0.02 (11%) S$ Page 15
Slide 17: Dividends
Financial Highlights Dividends S$’Million N1 Dividend Paid/Proposed (S$’Million) Q2 2024 (Interim Dividend) 1.7 Q4 2024 (Final Dividend) 4.0 Total 5.7 (N1) N1 – Includes final dividend of 0.70 Singapore Cents proposed but not yet approved by the shareholders; to be tabled for approval in the AGM on
Slide 18: Corporate Developments
Corporate Developments Page 17
Slide 19: 2024 – Significant Milestones
Corporate Developments 2024 – Significant Milestones Continue to next slide July 2024 September 2024 ISEC Melaka has obtained the operating licence Three new eye centres from the Ipoh Eye from the Ministry of Health Malaysia to operate Transaction (ME Centre, TE Centre and Taiping Eye) an outpatient
Slide 20: 2024 – Significant Milestones
Corporate Developments 2024 – Significant Milestones (for illustration only) September 2024 ISEC KL has fulfilled all conditions precedent of the Sale and Purchase Agreement which was entered into in December 2023, to acquire certain strata-title units totalling 69,445 sqft within a 15-storey buildi
Slide 21: Corporate Developments 2025
Corporate Developments 2025 Klang • ISEC Klang, a new addition of eye centre to the Group located in the city of Klang, State of Selangor in Malaysia, has obtained licenses from the relevant authorities, and commenced its operations in March 2025. Seremban • The Group has entered into a Joint Ventur
Slide 22: Outlook
Outlook Page 21
Slide 23: Outlook
Outlook • We remain positive about the outlook for our Group as we are well-positioned to capture the growing demand for private eye care services. • As the region ages and current lifestyle patterns continue to be highly influenced by digitalisation, we believe that there will be greater awareness
Slide 24: Outlook – Political Situation in Myanmar
Outlook Political Situation in Myanmar • As Myanmar continues to be in a state of emergency, the Group remains cautiously optimistic and is closely monitoring our clinic operations in Myanmar. • Notwithstanding the political issues in Myanmar, we are very much encouraged by the performance of our ey
Slide 25: Thank You
Thank You Page 24